Tolvaptan dose pack
Ended Awarded
- Contract number
- 36C25220F0443
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $10,035
Award facts
- Contract value 100% obligated
- $10,034.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
On September 9, 2020, the Department of Veterans Affairs, Veterans Integrated Service Network 12, awarded a $10,034.63 delivery order to Otsuka America Pharmaceutical Inc. for tolvaptan dose packs to be delivered to Pittsburgh, Pennsylvania. This firm-fixed-price contract was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and carries an ultimate completion date of October 10, 2020. The award utilized no set-aside designation, reflecting the vendor's status as an established pharmaceutical supplier to the VA system.
This delivery order is part of a larger indefinite delivery vehicle consisting of an $83.3 million Blanket Purchase Agreement awarded to Otsuka America Pharmaceutical Inc. by the National Acquisition Center for tolvaptan (marketed as Jynarque), a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. The BPA, which extends through March 26, 2026, enables VA Integrated Service Networks across the country to procure this critical medication for veterans. Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer headquartered in Rockville, Maryland, maintains significant federal supply schedule contracts with the VA and supplies specialty pharmaceuticals to multiple VA facilities nationwide.
Quick answers
Who was awarded contract 36C25220F0443?
36C25220F0443 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on September 9, 2020.
How much is contract 36C25220F0443 worth?
The government has obligated $10,035 on 36C25220F0443.
Is contract 36C25220F0443 an order under another contract?
Yes. 36C25220F0443 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25220F0443 competed?
The extent of competition for 36C25220F0443 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award